Accessing the brain: the nose may know the way.
作者信息
Djupesland Per G, Mahmoud Ramy A, Messina John C
机构信息
OptiNose US Inc, Yardley, Pennsylvania, USA.
出版信息
J Cereb Blood Flow Metab. 2013 May;33(5):793-4. doi: 10.1038/jcbfm.2013.41. Epub 2013 Mar 13.
Abstract
摘要
相似文献
1
Accessing the brain: the nose may know the way.进入大脑：鼻子可能知道路。
J Cereb Blood Flow Metab. 2013 May;33(5):793-4. doi: 10.1038/jcbfm.2013.41. Epub 2013 Mar 13.
2
Blood-brain barrier transport of drugs for the treatment of brain diseases.血脑屏障转运药物治疗脑部疾病。
CNS Neurol Disord Drug Targets. 2009 Jun;8(3):195-204. doi: 10.2174/187152709788680652.
3
Drug transport across the blood-brain barrier.药物穿越血脑屏障的转运。
J Cereb Blood Flow Metab. 2012 Nov;32(11):1959-72. doi: 10.1038/jcbfm.2012.126. Epub 2012 Aug 29.
4
Modern methods for delivery of drugs across the blood-brain barrier.现代跨越血脑屏障递药方法。
Adv Drug Deliv Rev. 2012 May 15;64(7):640-65. doi: 10.1016/j.addr.2011.11.010. Epub 2011 Nov 28.
5
The role of drug transporters at the blood-brain barrier.药物转运体在血脑屏障中的作用。
Annu Rev Pharmacol Toxicol. 2003;43:629-56. doi: 10.1146/annurev.pharmtox.43.100901.140204. Epub 2002 Jan 10.
6
The highly permeable blood-brain barrier: an evaluation of current opinions about brain uptake capacity.高通透性血脑屏障：对当前关于脑摄取能力观点的评估
Drug Discov Today. 2007 Dec;12(23-24):1076-82. doi: 10.1016/j.drudis.2007.10.005. Epub 2007 Nov 26.
7
Blood-brain barrier: an impediment to neuropharmaceuticals.血脑屏障：神经药物的一个障碍。
Clin Pharmacol Ther. 2015 Apr;97(4):308-13. doi: 10.1002/cpt.77. Epub 2015 Feb 24.
8
Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions.载体介导的药物摄取和外排：药物不良反应的重要决定因素。
Clin Pharmacol Ther. 2011 Jun;89(6):798-805. doi: 10.1038/clpt.2010.354. Epub 2011 Apr 6.
9
Prodrug approaches to reduce hyperexcitation in the CNS.前药策略降低中枢神经系统过度兴奋。
Adv Drug Deliv Rev. 2012 May 15;64(7):666-85. doi: 10.1016/j.addr.2011.11.007. Epub 2011 Nov 27.
10
Zebrafish as a model to study drug transporters at the blood-brain barrier.斑马鱼作为血脑屏障药物转运体研究的模型。
Clin Pharmacol Ther. 2012 Nov;92(5):567-70. doi: 10.1038/clpt.2012.168. Epub 2012 Oct 10.
引用本文的文献
1
Laminar Fluid Ejection for Olfactory Drug Delivery: A Proof of Concept Study.用于嗅觉给药的层流流体喷射：一项概念验证研究。
IEEE J Transl Eng Health Med. 2024 Nov 20;12:727-738. doi: 10.1109/JTEHM.2024.3503498. eCollection 2024.
2
Translational Considerations in the Development of Intranasal Treatments for Epilepsy.癫痫鼻内治疗开发中的转化考量
Pharmaceutics. 2023 Jan 10;15(1):233. doi: 10.3390/pharmaceutics15010233.
3
Sesame Oil-Based Nanostructured Lipid Carriers of Nicergoline, Intranasal Delivery System for Brain Targeting of Synergistic Cerebrovascular Protection.基于芝麻油的尼麦角林纳米结构脂质载体，用于脑靶向协同脑血管保护的鼻内给药系统。
Pharmaceutics. 2021 Apr 19;13(4):581. doi: 10.3390/pharmaceutics13040581.
4
Intranasal drug delivery: opportunities and toxicologic challenges during drug development.鼻腔内给药：药物开发过程中的机遇和毒理学挑战。
Drug Deliv Transl Res. 2022 Apr;12(4):735-757. doi: 10.1007/s13346-020-00891-5. Epub 2021 Jan 25.
5
Oxytocin modulates local topography of human functional connectome in healthy men at rest.催产素调节健康男性静息时局部功能连接组拓扑结构。
Commun Biol. 2021 Jan 15;4(1):68. doi: 10.1038/s42003-020-01610-z.
6
Effects of haloperidol inhalation on MK-801- and memantine-induced locomotion in mice.氟哌啶醇吸入对 MK-801 和盐酸美金刚诱导的小鼠运动的影响。
Libyan J Med. 2020 Dec;15(1):1808361. doi: 10.1080/19932820.2020.1808361.
7
Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans.给药途径对催产素引起的人类局部脑血流变化的影响。
Nat Commun. 2020 Mar 3;11(1):1160. doi: 10.1038/s41467-020-14845-5.
8
Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine.鼻腔内免疫接种用铝盐佐剂干粉疫苗。
J Control Release. 2018 Dec 28;292:111-118. doi: 10.1016/j.jconrel.2018.10.020. Epub 2018 Oct 16.
9
Low-dose intranasal oxytocin delivered with Breath Powered device modulates pupil diameter and amygdala activity: a randomized controlled pupillometry and fMRI study.呼吸动力给药的低剂量鼻内催产素调节瞳孔直径和杏仁核活动：一项随机对照瞳孔测量和 fMRI 研究。
Neuropsychopharmacology. 2019 Jan;44(2):306-313. doi: 10.1038/s41386-018-0241-3. Epub 2018 Oct 16.
10
Activation of cyclin D1 affects mitochondrial mass following traumatic brain injury.创伤性脑损伤后细胞周期蛋白 D1 的激活会影响线粒体质量。
Neurobiol Dis. 2018 Oct;118:108-116. doi: 10.1016/j.nbd.2018.07.010. Epub 2018 Jul 18.
本文引用的文献
1
Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review.鼻腔给药装置：临床视角下的特点和性能——综述。
Drug Deliv Transl Res. 2013 Feb;3(1):42-62. doi: 10.1007/s13346-012-0108-9. Epub 2012 Oct 18.
2
Intranasal treatment of central nervous system dysfunction in humans.经鼻治疗人类中枢神经系统功能障碍。
Pharm Res. 2013 Oct;30(10):2475-84. doi: 10.1007/s11095-012-0915-1. Epub 2012 Nov 8.
3
Drug transport across the blood-brain barrier.药物穿越血脑屏障的转运。
J Cereb Blood Flow Metab. 2012 Nov;32(11):1959-72. doi: 10.1038/jcbfm.2012.126. Epub 2012 Aug 29.
4
Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles.小麦胚凝集素偶联的 PEG-PLA 纳米粒的经鼻脑递药途径。
Pharm Res. 2012 Feb;29(2):546-58. doi: 10.1007/s11095-011-0641-0. Epub 2011 Dec 14.
5
Intranasal delivery of biologics to the central nervous system.经鼻内递送至中枢神经系统的生物制剂。
Adv Drug Deliv Rev. 2012 May 15;64(7):614-28. doi: 10.1016/j.addr.2011.11.002. Epub 2011 Nov 15.
6
Nasal saline irrigations for the symptoms of chronic rhinosinusitis.用生理盐水冲洗鼻腔治疗慢性鼻-鼻窦炎症状。
Cochrane Database Syst Rev. 2007 Jul 18(3):CD006394. doi: 10.1002/14651858.CD006394.pub2.
7
The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain.由动脉搏动驱动的“血管周围泵”是一种在脑内分布治疗性分子的强大机制。
Mol Ther. 2006 Jul;14(1):69-78. doi: 10.1016/j.ymthe.2006.02.018. Epub 2006 May 2.
8
Direct access of drugs to the human brain after intranasal drug administration?鼻内给药后药物能否直接进入人脑？
Neurology. 2003 May 27;60(10):1669-71. doi: 10.1212/01.wnl.0000067993.60735.77.
9
Anterior distribution of human olfactory epithelium.人类嗅觉上皮的前部分布。
Laryngoscope. 2000 Mar;110(3 Pt 1):417-21. doi: 10.1097/00005537-200003000-00016.
10
Uptake of exogenous proteins in mouse olfactory cells.小鼠嗅觉细胞中外源蛋白质的摄取
Acta Neuropathol. 1971;19(2):145-54. doi: 10.1007/BF00688493.
Zotero 插件